MAYO CLINIC
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Use of Pyridostigmine for Constipation in Diabetics
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2012-11-30
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT00276406
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2011-05-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 22
- Registration Number
- NCT00276393
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Rapid Bedside cTnl on Outcome.
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2010-01-28
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 350
- Registration Number
- NCT00276432
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Topical Steroid Treatment for Eosinophilic Esophagitis
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2012-05-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 42
- Registration Number
- NCT00275561
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2013-01-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT00275613
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Flaxseed for the Treatment of Hot Flashes
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2011-06-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT00275704
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2011-12-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 165
- Registration Number
- NCT00275535
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 6
- Registration Number
- NCT00275652
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
Development of a Hospital Service That Uses Critical Pathway (Protocolized) Care Plans to Provide High-Quality, High-Reliability, Evidence-Based Medical Care
Completed
- Conditions
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2011-03-23
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 348
- Registration Number
- NCT00275587
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.
Completed
- Conditions
- First Posted Date
- 2006-01-12
- Last Posted Date
- 2010-12-22
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 60
- Registration Number
- NCT00275717
- Locations
- ๐บ๐ธ
Mayo Clinic, Rochester, Minnesota, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath